dendritic cell therapy (CFR Pharmaceuticals)

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug Namedendritic cell therapy (CFR Pharmaceuticals)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy
Mechanisms of ActionImmunosuppressants
TargetsUpdating
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryChile
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCFR Pharmaceuticals SA
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCFR Pharmaceuticals SA
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A